Clinical Trials Directory

Trials / Conditions / BK Virus Nephropathy

BK Virus Nephropathy

8 registered clinical trials studyying BK Virus Nephropathy.

StatusTrialSponsorPhase
CompletedPrediction of BK Virus Reactivation in Kidney Transplant Recipient
NCT06219616
King Chulalongkorn Memorial HospitalN/A
CompletedAssess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers.
NCT05358106
Memo Therapeutics AGPhase 1
CompletedStudy of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia
NCT04605484
AlloVirPhase 2
UnknownEvaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation
NCT04506060
Centre Hospitalier Universitaire, Amiens—
WithdrawnDetermine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney
NCT03456999
Novartis PharmaceuticalsPhase 2
Active Not RecruitingVIRTUUS Children's Study
NCT03719339
Children's Hospital of Philadelphia—
WithdrawnBK Virus Post-Kidney Transplant: New Practice Versus Traditional Approach
NCT02758288
Loma Linda University—
TerminatedCidofovir in Renal Transplant Recipients With BKVN
NCT00138424
National Institute of Allergy and Infectious Diseases (NIAID)Phase 1 / Phase 2